{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:51:39Z","timestamp":1789689099261,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI157312"],"award-info":[{"award-number":["R01AI157312"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI090810"],"award-info":[{"award-number":["R01AI090810"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["F31AI169961"],"award-info":[{"award-number":["F31AI169961"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tube.2024.102592","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T07:45:40Z","timestamp":1734075940000},"page":"102592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of tetracycline analogues with increased aqueous stability for the treatment of mycobacterial infections"],"prefix":"10.1016","volume":"150","author":[{"given":"Jiuyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Loudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina N.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennen T.","family":"Troyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Obregon-Henao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2397-0443","authenticated-orcid":false,"given":"Richard E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2024.102592_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.tube.2024.102592_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0014-5793(87)81539-9","article-title":"Competition between tetracycline and tRNA at both P and A sites of the ribosome of Escherichia coli","volume":"213","author":"Epe","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.tube.2024.102592_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s002030050339","article-title":"Tetracyclines: antibiotic action, uptake, and resistance mechanisms","volume":"165","author":"Schnappinger","year":"1996","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.tube.2024.102592_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","article-title":"The history of the tetracyclines","volume":"1241","author":"Nelson","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.tube.2024.102592_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.257.5073.1064","article-title":"The crisis in antibiotic resistance","volume":"257","author":"Neu","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.tube.2024.102592_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00018-009-0172-6","article-title":"The tetracycline resistome","volume":"67","author":"Thaker","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tube.2024.102592_bib7","doi-asserted-by":"crossref","first-page":"a025387","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.tube.2024.102592_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/AAC.44.4.943-949.2000","article-title":"In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria","volume":"44","author":"Van Ogtrop","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0960-894X(99)00216-4","article-title":"Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936","volume":"9","author":"Sum","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"issue":"Suppl 5","key":"10.1016\/j.tube.2024.102592_bib10","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1086\/431672","article-title":"Tigecycline: a new glycylcycline for treatment of serious infections","volume":"41","author":"Noskin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2024.102592_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/AAC.43.4.738","article-title":"In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936)","volume":"43","author":"Petersen","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib12","first-page":"311","article-title":"In vitro effect of tigecycline against Mycobacterium tuberculosis and a review of the available drugs for tuberculosis","volume":"5","author":"Coban","year":"2011","journal-title":"Afr J Microbiol Res"},{"key":"10.1016\/j.tube.2024.102592_bib13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1183\/09031936.00113713","article-title":"Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis","volume":"43","author":"Alsaad","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2024.102592_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijantimicag.2014.11.017","article-title":"Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis","volume":"45","author":"Gonzalo","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2024.102592_bib15","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/AAC.03112-15","article-title":"Tigecycline is highly efficacious against Mycobacterium abscessus pulmonary disease","volume":"60","author":"Ferro","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00470-19","article-title":"In vitro activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib17","article-title":"In vitro susceptibility testing of eravacycline against nontuberculous mycobacteria","volume":"66","author":"Brown-Elliott","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib18","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","article-title":"Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2024.102592_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","article-title":"Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease","volume":"23","author":"Dartois","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.tube.2024.102592_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116435","article-title":"In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: a meta-analysis study","volume":"110","author":"Zhang","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2024.102592_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00119-18","article-title":"High levels of intrinsic tetracycline resistance in Mycobacterium abscessus are conferred by a tetracycline-modifying monooxygenase","volume":"62","author":"Rudra","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib24","doi-asserted-by":"crossref","first-page":"52346","DOI":"10.1074\/jbc.M409573200","article-title":"TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics","volume":"279","author":"Yang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tube.2024.102592_bib25","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0149-2918(04)90070-7","article-title":"Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients","volume":"26","author":"Postier","year":"2004","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.tube.2024.102592_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.49.1.220-229.2005","article-title":"Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects","volume":"49","author":"Muralidharan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib28","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/AAC.49.9.3903-3909.2005","article-title":"Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent Oxyrase to standardize the test method","volume":"49","author":"Bradford","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/dki386","article-title":"Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines","volume":"56","author":"Hope","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095281","article-title":"A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity","volume":"9","author":"Jitkova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2024.102592_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102269","article-title":"Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria","volume":"137","author":"Shankar","year":"2022","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2024.102592_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2024.102519","article-title":"Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation","volume":"147","author":"Boorgula","year":"2024","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2024.102592_bib33","first-page":"121","article-title":"Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus","author":"Phelps","year":"2024","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2024.102592_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-20","article-title":"In vitro susceptibility testing of omadacycline against nontuberculous mycobacteria","volume":"65","author":"Brown-Elliott","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00090-23","article-title":"Novel synergies and isolate specificities in the drug interaction landscape of Mycobacterium abscessus","volume":"67","author":"Van","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-20","article-title":"In vitro susceptibility testing of omadacycline against nontuberculous mycobacteria","volume":"65","author":"Brown-Elliott","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm.3458","article-title":"Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux","volume":"20","author":"Lee","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2024.102592_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/acsinfecdis.6b00158","article-title":"Structure\u2013activity relationships of spectinamide antituberculosis agents: a dissection of ribosomal inhibition and native efflux avoidance contributions","volume":"3","author":"Liu","year":"2017","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2024.102592_bib39","article-title":"Synthesis and antibacterial action of 3',6'-disubstituted spectinomycins","author":"Dharuman","year":"2024","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.tube.2024.102592_bib40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jac\/dki436","article-title":"Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum","volume":"57","author":"Ramon-Garcia","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib41","doi-asserted-by":"crossref","first-page":"14046","DOI":"10.1021\/acs.jmedchem.1c01215","article-title":"Bioisosteres of the phenyl ring: recent strategic applications in lead optimization and drug design","volume":"64","author":"Subbaiah","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2024.102592_bib42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/jac\/dkaa110","article-title":"Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo","volume":"75","author":"Pearce","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib43","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2024.102592_bib44","series-title":"TYGACIL, package insert","year":"2010"},{"key":"10.1016\/j.tube.2024.102592_bib45","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1107\/S0907444913013802","article-title":"Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX","volume":"69","author":"Volkers","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.tube.2024.102592_bib46","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/cb400399b","article-title":"Molecular insight into substrate recognition and catalysis of Baeyer-Villiger monooxygenase MtmOIV, the key frame-modifying enzyme in the biosynthesis of anticancer agent mithramycin","volume":"8","author":"Bosserman","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.tube.2024.102592_bib47","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M116.745315","article-title":"The structure of the antibiotic deactivating, N-hydroxylating rifampicin monooxygenase","volume":"291","author":"Liu","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tube.2024.102592_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1021\/acs.jcim.3c01531","article-title":"X-Ray crystallography module in MD simulation program amber 2023. Refining the models of protein crystals","volume":"64","author":"Mikhailovskii","year":"2024","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.tube.2024.102592_bib49","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1006\/jmbi.1998.2401","article-title":"Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation","volume":"285","author":"Word","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.tube.2024.102592_bib50","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J Chem Theor Comput"},{"key":"10.1016\/j.tube.2024.102592_bib51","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T09:11:32Z","timestamp":1735809092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979224001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S1472979224001203"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2024.102592","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of tetracycline analogues with increased aqueous stability for the treatment of mycobacterial infections","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2024.102592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102592"}}